Despite their relatively low binding affinity compared to synthetic DNMT inhibitors, these natural compounds offer a safer profile for long-term use, especially in pre-cancerous lesions, chronic inflammation-related cancers, or maintenance therapy. Here, DNMT1 is linked to cancer.